Multi-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML.
Zhao C, Jia B, Wang M, Schell TD, Claxton DF, Ehmann WC, Rybka WB, Mineishi S, Naik S, Songdej N, Sivik JM, Hohl RJ, Zeng H, Zheng H.
Zhao C, et al. Among authors: sivik jm.
Br J Haematol. 2020 Mar;188(5):674-684. doi: 10.1111/bjh.16228. Epub 2019 Oct 1.
Br J Haematol. 2020.
PMID: 31573077
Free PMC article.
Clinical Trial.